Functional Rewiring of Three Pneumococcal Proteins Into Plasminogen Binders

Yoshihito Yasui1,2, Satoru Hirayama1, Hisanori Domon1,3

  • 1Division of Microbiology and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

PubMed

Insights

Streptococcus pneumoniae uses specific proteins to bind human plasminogen, aiding infection. This binding facilitates plasmin formation, suggesting a key role in pneumococcal pathogenesis.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Pneumococcal infections pose significant public health challenges.
  • Understanding the molecular mechanisms of Streptococcus pneumoniae pathogenesis is crucial for developing effective treatments.
  • Previous proteomic analysis identified potential virulence factors in infected mouse models.

Purpose of the Study:

  • To investigate the role of specific pneumococcal proteins in host-pathogen interactions.
  • To characterize the interaction between identified pneumococcal proteins and human plasminogen.
  • To elucidate the mechanism by which these proteins might contribute to pneumococcal infection.

Main Methods:

  • Proteomic analysis of infected mouse samples to identify pneumococcal proteins.
  • Biochemical characterization of three selected proteins: ATP synthase subunit beta (AtpD), ABC transporter transmembrane protein (Vex3), and fructose bisphosphate aldolase (Fba).
  • Assays to determine the binding of these proteins to human plasminogen and their effect on plasminogen activation by tissue-type plasminogen activator.

Main Results:

  • Three pneumococcal proteins, AtpD, Vex3, and Fba, were identified to bind human plasminogen.
  • These proteins were found to facilitate the conversion of plasminogen to plasmin by tissue-type plasminogen activator.
  • This interaction suggests a mechanism for Streptococcus pneumoniae to exploit host proteolytic systems.

Conclusions:

  • Streptococcus pneumoniae proteins AtpD, Vex3, and Fba play a role in binding and activating human plasminogen.
  • The exploitation of plasminogen's proteolytic activity may be a significant virulence factor in pneumococcal infections.
  • Targeting these plasminogen-binding proteins could represent a novel therapeutic strategy against pneumococcal disease.